Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?

Welcome & Introducion

Date

15 Sep 2024

Session

Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?

Topics

Basic Science;  Cancer Research

Tumour Site

Presenters

Martin Wermke

Authors

M. Wermke

Author affiliations

  • Early Clinical Trial Dept., Dresden University, 01187 - Dresden/DE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Selectively targeting HER2 in NSCLC

Presenter: Jon Zugazagoitia

Session: Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?

Resources:

Webcast

Panel discussion and audience Q&A

Presenter: Martin Wermke, Gerrina Ruiter, Jon Zugazagoitia

Session: Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.